Well, jaybull, you are a real doofus. It... says nothing of the sort. THIS/// ISN'T A FORM 13D. Are you able to read or use google?!?
They might have added 1 or 2, but yes, it is accurate... the main compound was purchased years ago and all they are doing is outsourcing trial production and running some simple tests with it and donepezil.
A wash sale means the price falls beyond your purchase price, and you sell and rebuy to put the sale as a loss for the calendar year. That means you expect the price to fall, except that is not what you were indicating in the rest of your sentence...
And no. A 13D is not a Form D. Have you ever used the SEC website or do you just go by rumors? "Notice of Exempt Offering of Securities, item 06b". Read it.
The problem with tax loss selling is that in one month, the share price might change. In this case, it was in your favor...
Why focus on the reverse split? Seems a lot of financially illiterate posters don't understand what a reverse split is.
Who is the fool? Maybe both of you. What kind of ssabmud big investor gets confused by a reverse split? The share price might be higher but the valuation the same.
Sientra does not own the manufacturer. The only thing they can do is attempt to assess the manufacturer's quality every once in a while. There isn't much they can do.
Hey athersyss, why don't you take a break with ATHX. Go on the AVXL messageboard and check out how similar they are to the pumping posts from earlier this year and last year.
Pumper with no command of English... how much do they pay you?
That person whose quote you are referring to is not talking about AVXL's drug at all. The video mis-matched another company's (failed) drug.